Tropicamide/Lidocaine/Phenylephrine

托品卡胺/利多卡因/去氧肾上腺素

Report date: 2026/02/13 10:40:11

Base Information

Drug NameTropicamide/Lidocaine/Phenylephrine
Drug Alias Name托品卡胺+利多卡因+去氧肾上腺素Tropicamide, Lidocaine and Phenylephrine托品卡胺•利多卡因•去氧肾上腺素Tropicamide•Lidocaine•PhenylephrineTropicamide-Lidocaine-Phenylephrine +[15] 
ClassificationSmall molecules
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsAdrenergic receptor alpha-1 agonists
TargetsSodium channel alpha subunitMuscarinic acetylcholine receptorAdrenergic receptors alpha-1
Therapy Area/IndicationsMydriasisCataractCorneal Endothelial Cell Loss +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEgypt
CombinationsYes Phenylephrine HydrochlorideLidocaineTropicamide
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Théa, France
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Théa, France
Inactive CompaniesCairo University
Active IndicationsMiosisAnesthesia
Inactive IndicationsMydriasisCataractCorneal Endothelial Cell Loss

Other Information

ATC CodeS01FA56
Related LinksN/A